
Pill that can slow breast cancer cleared for NHS use
AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available.
Newsletters and Deep Dive digital magazine
AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available.
The first targeted drug for a common form of bladder cancer that can be taken at home. J&J's Balversa, has been backed for NHS use.
HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.
The first biosimilars of AstraZeneca/Alexion's blockbuster complement C5 inhibitor Soliris have been launched in the US at a discount to the brand.
The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.
Editor's Picks
Newsletters and Deep Dive
digital magazine